Literature DB >> 7668896

Ankylosing spondylitis, IgA, and transforming growth factors.

J R Archer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7668896      PMCID： PMC1009930          DOI： 10.1136/ard.54.7.544

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  34 in total

1.  Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.

Authors:  H Hocini; S Iscaki; C Benlahrache; L Vitalis; X Chevalier; B Larget-Piet; J P Bouvet
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Effects of transforming growth factor beta-1 and interleukin-5 on IgA isotype switching at the clonal level.

Authors:  M F Kagnoff; P H Kim
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Wideman; J Y Bonnefoy; J E De Vries
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

4.  An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation.

Authors:  C Díaz-Gallo; M Moscovitch-Lopatin; T B Strom; V R Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

5.  A protective NOD islet-infiltrating CD8+ T cell clone, I.S. 2.15, has in vitro immunosuppressive properties.

Authors:  O G Pankewycz; J X Guan; J F Benedict
Journal:  Eur J Immunol       Date:  1992-08       Impact factor: 5.532

6.  Differential activation of CD8+ T cells by transforming growth factor-beta 1.

Authors:  H M Lee; S Rich
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

7.  Transforming growth factor-beta directs IgA switching in human B cells.

Authors:  P van Vlasselaer; J Punnonen; J E de Vries
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

Review 8.  Molecular heterogeneity of human IgA antibodies during an immune response.

Authors:  M W Russell; C Lue; A W van den Wall Bake; Z Moldoveanu; J Mestecky
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

9.  Cloning and expression of class I major histocompatibility complex genes of the rat.

Authors:  S C Jameson; W D Tope; E M Tredgett; J M Windle; A G Diamond; J C Howard
Journal:  J Exp Med       Date:  1992-06-01       Impact factor: 14.307

10.  Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

Authors:  T Defrance; B Vanbervliet; F Brière; I Durand; F Rousset; J Banchereau
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307
View more
  7 in total

1.  Susceptibility to ankylosing spondylitis: evidence for the role of ERAP1, TGFb1 and TLR9 gene polymorphisms.

Authors:  Wenliang Wu; Yan Ding; Yunzhen Chen; Zhao Hua; Haichun Liu; Hongliang Wang; Guangjun Jiao
Journal:  Rheumatol Int       Date:  2011-07-16       Impact factor: 2.631

Review 2.  The synovio-entheseal complex in enthesoarthritis.

Authors:  Angelo De Cata; Michele Inglese; Rosa Rubino; Francesca Molinaro; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2015-02-12       Impact factor: 3.984

3.  Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms.

Authors:  M van der Paardt; J B A Crusius; M A García-González; B A C Dijkmans; A S Peña; I E van der Horst-Bruinsma
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 4.  Pathways of cell activation in spondyloarthropathies.

Authors:  U Fearon; D J Veale
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

5.  Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis.

Authors:  Gianna Elena Hammer; Emre E Turer; Kimberly E Taylor; Celia J Fang; Rommel Advincula; Shigeru Oshima; Julio Barrera; Eric J Huang; Baidong Hou; Barbara A Malynn; Boris Reizis; Anthony DeFranco; Lindsey A Criswell; Mary C Nakamura; Averil Ma
Journal:  Nat Immunol       Date:  2011-10-23       Impact factor: 25.606

6.  Widespread scleredema accompanied with a monoclonal gammopathy in a patient with advanced ankylosing spondylitis.

Authors:  Hyun Kyu Chang; You Chan Kim; Bum Sun Kwon
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

7.  Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Authors:  Jialing Wu; Xinyu Wu; Zena Chen; Qing Lv; Mingcan Yang; Xuqi Zheng; Qiuxia Li; Yanli Zhang; Qiujing Wei; Shuangyan Cao; Xiaomin Li; Jun Qi; Minjing Zhao; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.